Schizophrenia Research
Volume 118, Issue 1 , Pages 168-175 , May 2010

DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: Psychometric validity and response to antipsychotic medication

Received 29 September 2009 ,Revised 1 December 2009 ,Accepted 19 December 2009.

References 

  1. Abrams R, Taylor MA. Catatonia: a prospective clinical study. Arch. Gen. Psychiatry. 1976;33:579–581
  2. Abrams R, Taylor MA, Storulow KAC. Catatonia and mania: patterns of cerebral dysfunction. Biol. Psychiatry. 1979;14:111–117
  3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fourth ed.. Washington, D.C: American Psychiatric Association; 1994;
  4. Andreasen NC, Endicott J, Spitzer RL, et al. The family history method using diagnostic criteria. Arch. Gen. Psychiatry. 1977;47:615–621
  5. Andreasen NC, Flaum M, Arndt S. The Comprehensive Assessment of Symptoms and Diagnosis. An instrument for assessing diagnosis and psychopathology. Arch. Gen. Psychiatry. 1992;49:615–623
  6. Barnes TRE. A rating scale for drug-induced akathisia. Br. J. Psychiatry. 1989;154:672–676
  7. Bleuler E. Dementia Praecox or the Group of Schizophrenias. New York, NY: International University Press; 1911;Translated by Zinkin, J.
  8. Blumer D. Catatonia and the neuroleptics: psychobiological significance of remote and recent findings. Comp. Psychiatry. 1997;38:193–201
  9. Bräuning P, Krüger S, Shugar G. Prevalence and clinical significance of catatonic symptoms in mania. Comp. Psychiatry. 1998;39:35–46
  10. Bräuning P, Krüger S, Shugar G. The Catatonia Rating Scale I — development, reliability, and use. Comp. Psychiatry. 2000;41:147–158
  11. Bush G, Fink M, Petrides G. Catatonia, I. Rating scale and standardized examination. Acta Psychiatr. Scand. 1996;93:129–136
  12. Bush G, Petrides G, Francis A. Catatonia and other motor syndromes in a chronically hospitalized psychiatric population. Schizophr. Res. 1997;27:83–92
  13. Caroff SN, Mann SC, Campbell EC, et al. Movement disorders associated with atypical antipsychotic drugs. J. Clin. Psychiatry. 2002;63(Suppll. 4):12–19
  14. Caroff SN, Mann SC, Campbell EC, et al. Epidemiology. In:  Caroff SM,  Mann SC,  Francis A, et al. editor. Catatonia: from Psychopathology to Neurobiology. Washington, DC: American Psychiatric Publishing Inc.; 2004;p. 15–31
  15. Cuesta MJ, Garcia de Jalon EG, Campos MS, et al. Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis. Br. J. Psychiatry. 2009;194:439–445
  16. Gelenberg AJ, Mandel MR. Catatonic reactions to high-potency neuroleptic drugs. Arch. Gen. Psychiatry. 1977;34:947–950
  17. Guy WA. Abnormal Involuntary Movement Scale (AIMS). In: ECDEU Assessment Manual for Psychopharmacology. Washington, DC: US Dept Health Education and Wellfare; 1976;p. 534–537
  18. Harris JG. Abbreviated form of the Phillips rating scale of premorbid adjustment in schizophrenia. J. Abnorm. Psychol. 1975;84:129–137
  19. Kahlbaum KL. Die Katatonie oder das Spannungirresein. Berlin: Verlag August Hirschwald; 1874;
  20. Kapur S, Mizrahi R, Li M. From dopamine to salience to psychosis: linking biology, pharmacology and phenomenology of psychosis. Schizophr. Res. 2005;79:59–68
  21. Kraepelin E. Dementia Praecox and Paraphrenia. Edinburgh: Livingstone; 1913;Translated by Barklay, R.M.
  22. Lund CE, Mortimer AM, Rogers D, et al. Motor, volitional and behavioural disorders in schizophrenia. 1: Assessment using the Modified Rogers Scale. Br. J. Psychiatry. 1991;158:323–327
  23. Martényi F, Metcalfe S, Schausberger B, et al. An efficacy analysis of olanzapine treatment data in schizophrenia patients with catatonic signs and symptoms. J. Clin. Psychiatry. 2001;62(suppl 2):25–27
  24. McKenna PJ, Lund C, Mortimer A, et al. Motor, volitional and behavioral disorders in schizophrenia. 2: the ‘conflict of paradigms’ hypothesis. Br. J. Psychiatry. 1991;158:328–336
  25. Morrison JR. Changes in subtype diagnosis of schizophrenia: 1920–1966. Am. J. Psychiatry. 1974;131:674–677
  26. Northoff G, Koch A, Wenke J, Eckert J, et al. Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms. Mov. Disord. 1999;14:404–416
  27. Oulis P, Likouras L, Tomaras V, et al. DSM-IV catatonic features among psychiatric inpatients: a preliminary study. Eur. Psychiatry. 1997;12:412–414
  28. Peralta V, Cuesta MJ. Negative, parkinsonian and catatonic symptoms in schizophrenia: a conflict of paradigms revisited. Schizophr. Res. 1999;40:245–253
  29. Peralta V, Cuesta MJ. How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophr. Res. 2001;49:269–285
  30. Peralta V, Cuesta MJ. Motor features in psychotic disorders. I. Factor structure and clinical correlates. Schizophr. Res. 2001;47:107–116
  31. Peralta V, Cuesta MJ. Motor features in psychotic disorders. II. Development of diagnostic criteria for catatonia. Schizophr. Res. 2001;47:117–126
  32. Peralta, V., Campos, M.S., Garcia de Jalon, E., et al. (in press). The effect of antipsychotic medication on neuromotor abnormalities in neuroleptic-naive nonaffective psychotic patients: A naturalistic study with haloperidol, risperidone or olanzapine. Prim. Care Companion J. Clin. Psychiatry. doi:10.4088/PPC.09m00799gry.
  33. Perkins DO, Leserman J, Jarskog LF, et al. Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory. Schizophr. Res. 2000;44:1–10
  34. Rogers D. The motor disorders of severe psychiatric illness: a conflict of paradigms. Br. J. Psychiatry. 1985;147:221–232
  35. Rosebush PI, Hildebrand AM, Furlong BG, et al. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation and response to lorazepam. J. Clin. Psychiatry. 1990;51:357–362
  36. Salokangas RK, Honkonen T, Stengard E. Negative symptoms and neuroleptics in catatonic schizophrenia. Schizophr. Res. 2003;59:73–76
  37. Simpson GM, Angus JWS. A rating scale for extrapyramidal side-effects. Acta Psychiat. Scand. 1970;212(suppl. 44):11–19
  38. Starkstein SE, Petracca G, Tesón A, et al. Catatonia in depression: prevalence, clinical correlates, and validation of a scale. J. Neurol. Neurosurg. Psychiat. 1996;60:326–332
  39. Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am. J. Psychiatry. 2003;160:1233–1241
  40. Ungvari GS, Leung SK, Shing F, et al. Schizophrenia with prominent catatonic features (‘catatonic schizophrenia’). I. Demographic and clinical correlates in the chronic phase. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2005;29:27–38
  41. Ungvari GS, Goggings W, Leung SK, et al. Schizophrenia with prominent catatonic features (‘catatonic schizophrenia’). II. Factor analysis of the catatonic syndrome. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2007;31:462–468
  42. Ungvari, G.S., Caroff, S.N., Gerevich, J., in press. The catatonia conundrum: evidence of psychomotor phenomena as a symptom dimension in psychotic disorders. Schizophr. Bull. doi:10-1093/schbul/sbp105.
  43. Valevski A, Loebl T, Keren T, et al. Response of catatonia to risperidone: two case reports. Clin. Neuropharm. 2001;24:51–59
  44. Van den Eede F, Sabbe B. Catatonia in psychiatric classification [letter]. Am. J. Psychiatry. 2003;161:1238–1239
  45. Van Den Eede F, Van Hecke A, Van Dalfsen A, et al. The use of atypical antipsychotic drugs in the treatment of catatonia. Eur. Psychiatry. 2005;20:422–429
  46. White DAC, Robins AH. Catatonia: harbinger of the neuroleptic malignant syndrome. Br. J. Psychiatry. 1991;158:419–421
  47. Wong E, Ungvari GS, Leung S-K, et al. Rating catatonia in patients with chronic schizophrenia: rash analysis of the Bush–Francis Catatonia Rating Scale. Int. J. Methods Psychiatr. Res. 2007;16:161–170
  48. World Health Organization. The ICD-10 classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research. Geneve: WHO; 1993;

PII: S0920-9964(09)00614-8

doi: 10.1016/j.schres.2009.12.023

Schizophrenia Research
Volume 118, Issue 1 , Pages 168-175 , May 2010